These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9237182)

  • 41. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?
    Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M
    J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.
    Randhawa PS; Jaffe R; Demetris AJ; Nalesnik M; Starzl TE; Chen YY; Weiss LM
    N Engl J Med; 1992 Dec; 327(24):1710-4. PubMed ID: 1331789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of Epstein-Barr virus in cardiac biopsies of heart transplant patients with lymphoproliferative disorders.
    Hanasono MM; Kamel OW; Chang PP; Rizeq MN; Billingham ME; van de Rijn M
    Transplantation; 1995 Sep; 60(5):471-3. PubMed ID: 7676496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey.
    Izadi M; Taheri S
    Ann Transplant; 2010; 15(4):102-9. PubMed ID: 21183884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-transplant lymphoproliferative disorders in kidney transplantation: histological and molecular genetic assessment.
    Koike J; Yamaguchi Y; Hoshikawa M; Takahashi H; Horita S; Tanabe K; Fuchinoue S; Toma H; Nihei H
    Clin Transplant; 2002; 16 Suppl 8():12-7. PubMed ID: 12464126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymerase chain reaction and in situ hybridization of Epstein-Barr virus in liver biopsy specimens facilitate the diagnosis of EBV hepatitis after liver transplantation.
    Barkholt L; Reinholt FP; Teramoto N; Enbom M; Dahl H; Linde A
    Transpl Int; 1998; 11(5):336-44. PubMed ID: 9787409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities?
    Trpkov K; Marcussen N; Rayner D; Lam G; Solez K
    Am J Kidney Dis; 1997 Sep; 30(3):449-54. PubMed ID: 9292579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleural posttransplantation lymphoproliferative disorder following liver transplantation.
    Hoffmann H; Schlette E; Actor J; Medeiros LJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):419-23. PubMed ID: 11231496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr virus encoded RNA detected by in situ hybridization using cytological preparations.
    Garady C; Saieg MA; Ko HM; Geddie WR; Boerner SL; da Cunha Santos G
    Cytopathology; 2014 Apr; 25(2):101-7. PubMed ID: 23725487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasmacytoma-like posttransplant lymphoproliferative disorder following orthotopic liver transplantation: a case report.
    Vishnu P; Jiang L; Cortese C; Menke DM; Tun HW
    Transplant Proc; 2011 Sep; 43(7):2806-9. PubMed ID: 21911168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoproliferative disorder masquerading as rejection in liver transplant recipients--an early aggressive tumor with atypical presentation.
    Howard TK; Klintmalm GB; Stone MJ; Cofer JB; Husberg BS; Goldstein RM; Gonwa TA
    Transplantation; 1992 May; 53(5):1145-7. PubMed ID: 1316652
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplant.
    Markin RS; Wood RP; Shaw BW; Brichacek B; Purtilo DT
    Am J Gastroenterol; 1990 Aug; 85(8):1014-8. PubMed ID: 2165351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in tonsils and adenoids in children with posttransplant lymphoproliferative disorder: report of three cases with early involvement of Waldeyer's ring.
    Lones MA; Mishalani S; Shintaku IP; Weiss LM; Nichols WS; Said JW
    Hum Pathol; 1995 May; 26(5):525-30. PubMed ID: 7750936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
    Kim RD; Fujikawa T; Mizuno S; Schwartz JJ; Sorensen JB; Hemming AW; Fujita S
    Eur J Gastroenterol Hepatol; 2011 Jul; 23(7):559-65. PubMed ID: 21555941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Obliterative arteriopathy in chronic rejection after hepatic transplantation. Search of cytomegalovirus genome by in situ hybridization and viral antigens by immunohistochemistry].
    Martin L; Sin A; Kantelip B; Mougin C; Heyd B; Miguet JP; Mantion G; Bresson-Hadni S; Lab M; Carbillet JP
    Gastroenterol Clin Biol; 1997; 21(4):259-64. PubMed ID: 9207992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease.
    Randhawa PS; Magnone M; Jordan M; Shapiro R; Demetris AJ; Nalesnik M
    Am J Surg Pathol; 1996 May; 20(5):563-71. PubMed ID: 8619421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance.
    Nelson BP; Locker J; Nalesnik MA; Fung JJ; Swerdlow SH
    Hum Pathol; 1998 Apr; 29(4):416-21. PubMed ID: 9563796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
    Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL
    Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.